Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
2021 · Nature Genetics · 522 citations
https://doi.org/10.1038/s41588-021-00973-1
A
Alma Osmanovic
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
2.1K
Citations
21
h-index
40
i10-index
Alma Osmanovic is an academic researcher from Medizinische Hochschule Hannover. The author has contributed to research in topics: Neurogenetic and Muscular Disorders Research & Amyotrophic Lateral Sclerosis Research & RNA modifications and cancer. The author has an h-index of 21, co-authored 60 publications.
ORCID: 0000-0002-6012-8423Papers by this author
worksSafety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial
2018 · The Lancet Neurology · 78 citations
https://doi.org/10.1016/s1474-4422(18)30176-5
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
2024 · The Lancet Regional Health - Europe · 56 citations
https://doi.org/10.1016/j.lanepe.2024.100862
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
2020 · Journal of Neurology · 54 citations
https://doi.org/10.1007/s00415-020-09847-8
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy
2024 · JAMA Pediatrics · 50 citations
https://doi.org/10.1001/jamapediatrics.2024.0492
Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany
2020 · Orphanet Journal of Rare Diseases · 36 citations
https://doi.org/10.1186/s13023-020-01413-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat